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Association of baseline hematoma and
edema volumes with one-year outcome
and long-term survival after spontaneous
intracerebral hemorrhage: A
community-based inception cohort study
James JM Loan1,2,3 , Angus B Gane2, Laura Middleton4,
Brendan Sargent5, Tom James Moullaali1 , Mark A Rodrigues1,4 ,
Laura Cunningham5, Joanna Wardlaw1,3 , Rustam Al-Shahi Salman1,2
and Neshika Samarasekera1,2
Abstract
Background: Hospital-based studies have reported variable associations between outcome after spontaneous intracer-
ebral hemorrhage and peri-hematomal edema volume.
Aims: In a community-based study, we aimed to investigate the existence, strength, direction, and independence of
associations between intracerebral hemorrhage and peri-hematomal edema volumes on diagnostic brain CT and one-
year functional outcome and long-term survival.
Methods: We identified all adults, resident in Lothian, diagnosed with first-ever, symptomatic spontaneous intracerebral
hemorrhage between June 2010 and May 2013 in a community-based, prospective inception cohort study. We defined regions
of interest manually and used a semi-automated approach to measure intracerebral hemorrhage volume, peri-hematomal
edema volume, and the sum of these measurements (total lesion volume) on first diagnostic brain CT performed at 3 days
after symptom onset. The primary outcome was death or dependence (scores 3–6 on the modified Rankin Scale) at one-year
after intracerebral hemorrhage.
Results: Two hundred ninety-two (85%) of 342 patients (median age 77.5 y, IQR 68–83, 186 (54%) female, median time
from onset to CT 6.5 h (IQR 2.9–21.7)) were dead or dependent one year after intracerebral hemorrhage. Peri-
hematomal edema and intracerebral hemorrhage volumes were colinear (R2¼ 0.77). In models using both intracerebral
hemorrhage and peri-hematomal edema, 10 mL increments in intracerebral hemorrhage (adjusted odds ratio (aOR) 1.72
(95% CI 1.08–2.87); p¼ 0.029) but not peri-hematomal edema volume (aOR 0.92 (0.63–1.45); p¼ 0.69) were independ-
ently associated with one-year death or dependence. 10 mL increments in total lesion volume were independently
associated with one-year death or dependence (aOR 1.24 (1.11–1.42); p¼ 0.0004).
Conclusion: Total volume of intracerebral hemorrhage and peri-hematomal edema, and intracerebral hemorrhage
volume alone on diagnostic brain CT, undertaken at three days or sooner, are independently associated with death
or dependence one-year after intracerebral hemorrhage, but peri-hematomal edema volume is not.
Data access statement: Anonymized summary data may be requested from the corresponding author.
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Background
Eighty-six percent of patients are dead or dependent
within one year of a spontaneous (non-traumatic) intra-
cerebral hemorrhage (ICH).1 Established predictors of
poor outcome after ICH include greater baseline ICH
volume, older age at onset, infratentorial location, and
intraventricular extension.2,3 Peri-hematomal edema
(PHE) is a radiological abnormality observed after
ICH which occupies a variable volume.4,5
Within the first week of ICH onset, PHE manifests
on CT brain scans as peri-hematomal hypoattenuation.
However, the association between PHE on diagnostic
brain CT and outcome is unclear. Of 16 cohort studies
examining this association, all were hospital-based, 5
studies recruited participants prospectively,6–10 and
only 4 studies adjusted for potential confounders.7,11–13
Eight studies stated the interval between symptom
onset and brain imaging, which varied from 212 to
2414 h.6,7,10–12,14–16 Eight studies found an association
between PHE and poor outcome, of which none ade-
quately adjusted for time from symptom onset to
scan,6–9,13,16–18 three studies found that PHE was asso-
ciated with better outcome,11,19,20 and five did not find
an association.10,12,14,15,21
Aims
We aimed to determine whether PHE measured on
baseline (diagnostic) brain CT after ICH is associated
with functional outcome and survival, independent of
known predictors of outcome, in a community-based
study.3
Methods
Design
We performed a prospective community-based incep-
tion cohort study to identify and follow adults aged
16 years who were resident in the Lothian Health
Board region of Scotland at the time of ICH.
Patients and follow-up
The Lothian Audit of the Treatment of Cerebral
Haemorrhage (LATCH) ascertained all patients with
first-ever spontaneous ICH onset between 1 June 2010
and 31 May 2013 while resident in the Lothian Health
Board region of Scotland, using hot pursuit of multiple
overlapping sources, as described previously.1 Patients
with secondary ICH (due to trauma, cerebral infarction
or underlying macrovascular lesion) or who underwent
diagnostic CT scan later than three days after symptom
onset were excluded. Other exclusion criteria are
detailed in Figure 1. We collected baseline demographic
and clinical variables, including drugs which might
affect ICH or PHE volume by interviewing patients
or their families at the time of presentation and review-
ing primary care and hospital records. We used mul-
tiple sources of follow-up including those used for case
ascertainment and questionnaires sent annually to each
participant’s GP to determine their vital status and
function according to the modified Rankin Scale
Figure 1. Patient selection flow diagram. ICH: intracerebral
hemorrhage; CT: computed tomography brain scan; mRS:
modified Rankin Scale.
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(mRS) score at one year. Survival was established by
surveillance of hospital and primary care.
Imaging
A neuroradiologist (MAR) reformatted the first diag-
nostic non-contrast CT brain images into standard
axial, coronal and sagittal planes of 5mm slice thick-
ness, MAR assessed ICH location according to The
Cerebral Haemorrhage Anatomical RaTing
inStrument (CHARTS)—from which lobar, deep, and
infratentorial groups were derived—and the presence of
intraventricular, subarachnoid or subdural extension
masked to clinical characteristics and outcome.22
Each scan was assessed by two of four raters (JJML,
ABG, LM, BS) who measured volumes of ICH and
PHE on each scan independently, masked to clinical
characteristics and outcome using Horos Viewer
(v3.3.5, Nimble Co LLC 2018).23 They manually
defined a region of interest (ROI) including ICH and
PHE but excluding ventricles, skull, and previous
stroke/small vessel disease on every slice showing ICH
or PHE of every scan. In this fashion, intraventricular
and extra-axial extension was excluded from analysis.
Within the included ROI, raters separately segmented
ICH and PHE in a semi-automated fashion by growing
regions from manually selected seeds using thresholds
of 40–100 Hounsfield Units (HU) for ICH and 5–33
HU for PHE.23,24 Individual raters adjusted thresholds
from these initial values manually to correct outlines
where the prespecified threshold incorrectly identified
the PHE edge. To determine intra-rater agreement
when measuring PHE, we first conducted a pilot of 40
scans with each rater analyzing 20 scans twice, with a
two-week minimum interval between ratings. Inter-
rater agreement was determined using the complete
cohort. Because ICH and PHE volume are often corre-
lated, PHE extension distance (EED) has been pro-
posed as a measure of PHE which is less correlated
with ICH volume.5,25 We measured EED in centimeters
(cm) (Supplementary material).5 We calculated lesion
volume as the sum of ICH and PHE volumes.
Outcomes
General practitioners rated functional outcome using
the mRS on annual postal questionnaires.26 The incep-
tion point was ICH symptom onset and follow-up con-
tinued until death or most recent completed annual
follow-up questionnaire.
Statistical analysis
We conducted analyses using Excel (v.16.37, Microsoft
2020), Prism (v8.4.2, Graphpad 2020), and R Core
(v3.6.2, 2019) run on R Studio (v 1.1.464, Boston
2015). As there is no universally accepted method for
determining sample size in multivariable regression, we
used the maximum available sample size obtainable for
the study period.27 We determined intra- and inter-rater
agreement using mixed and random effects models,
respectively, measured by intraclass correlation
(ICC).28 We prespecified outcome measures and pri-
mary multivariable analyses in a written protocol
(Supplementary material). For each case, we used the
mean ICH volume and PHE volume measured by two
raters for analyses. We dichotomized mRS for analysis
into 0–2, signifying good outcome, and 3–6 signifying
poor outcome (dead or dependent).
We conducted univariate comparisons between
patients with or without the primary outcome at one
year using Fisher’s exact, Mann Whitney U, or
unpaired t tests, as appropriate. We used log
rank tests to test for univariate associations of quartiles
of total lesion volume with long-term survival. We
used simple linear and cubic regression to assess collin-
earity and determined R2 using the least-squares
method. We calculated completeness of follow-up for
functional outcome at one year by dividing the sum of
follow-up times (days) by the sum of potential follow-
up to death or the end of the one year follow-up
period.29
We conducted multivariable analyses of associations
with mRS at one year using binomial logistic regression
with the primary independent variables of PHE
volume, EED or ICH volume. As few patients were
missing follow-up data at one year, these cases were
dropped from this analysis and no data imputed. Two
prespecified analyses included EED and ICH volume
and PHE and ICH volume as primary independent
variables. After finding PHE and ICH volumes were
collinear, we performed exploratory analyses using
total lesion volume as the primary independent vari-
able. Since any association between PHE and func-
tional outcome may vary by ICH location, we
performed subgroup analyses of the lobar ICH sub-
group and the subgroup with deep or infratentorial
ICH combined.30 We also undertook a supplementary
stratified analysis by restricting to quartiles of ICH
volume. We adjusted all analyses for the following pre-
specified covariates which were derived from the ICH
score: infratentorial ICH location, age at symptom
onset, admission Glasgow Coma score (trichotomized
3–4; 5–12; 13–15); and the presence of intraventricular
hemorrhage (IVH).3 As time from ICH symptom onset
to diagnostic CT scan is associated with greater PHE
volume within the first three days of onset, we under-
took one further sensitivity analysis using the add-
itional covariable of time (per 6 h, or fraction thereof)
from symptom onset or when last seen well to CT.31
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Table 1. Clinical characteristics of patients according to one-year functional outcome after first-ever spontaneous ICH.
Characteristic All
Year 1 mRS
unknown
Independence
(mRS 0–2)
Death or
dependence
(mRS 3–6)
Unadjusted
comparison mRS
0–2 vs. mRS 3–6
n 356 14 50 292
Female sex 193 (54%) 7 (50%) 27 (54%) 159 (55%) >0.999*
Median age (years) 78 (68–83) 78 (67–84) 69 (57–77) 79 (71–84) <0.001y
Median time to CT scan (h)a 6.5 (2.9–21.7) 17 (7.5–24.9) 7.7 (3.1–27.4) 6.2 (2.8–18.9) 0.24y
ICH characteristics
Median ICH volume (mL) 22 (8–51) 5 (4–13) 9 (3–14) 29 (9–61) <0.001y
Median peri-hematomal
edema volume (mL)
25 (12–48) 11 (8–20) 12 (5–18) 29 (14–55) <0.001y
Median total lesion volume (mL) 48 (20–98) 16 (11–37) 23 (7–32) 58 (25–115) <0.001y
Median ICH radius (cm) 1.8 (1.2–2.3) 1.1 (1.0–1.5) 1.3 (0.8–1.5) 1.9 (1.3–2.4) <0.001y
Mean edema extension
distance (cm)
3.1 (2.4–3.8) 2.3 (2.0–2.9) 2.5 (1.8–2.7) 3.3 (2.6–4.0) <0.001z
ICH location 0.43*
Lobar 170 (48%) 6 (43%) 22 (44%) 142 (49%)
Deep supratentorial 138 (39%) 7 (50%) 23 (46%) 108 (37%)
Infratentorial 48 (14%) 1 (7%) 5 (10%) 42 (14%)
Initial Glasgow coma scale score <0.001*
13–15 201 (57%) 13 (93%) 45 (90%) 143 (49%)
5–12 117 (33%) 1 (7%) 4 (8%) 112 (38%)
3–4 38 (11%) 0 (0%) 1 (2%) 37 (13%)
Intraventricular hemorrhage 179 (50%) 1 (7%) 10 (20%) 168 (58%) <0.001*
Subarachnoid hemorrhage 156 (44%) 4(29%) 16 (32%) 136 (47%) 0.065
Subdural hemorrhage 39 (11%) 1 (7%) 3 (6%) 35 (12%) 0.33
Deaths
30-day case fatality 162 (46%) 0 (0%) 0 (0%) 162 (55%) <0.001*
Deaths at end of study period 293 (82%) 11 (79%) 17 (34%) 265 (91%) <0.001*
Data are presented as n (%), median (interquartile range), or mean (standard deviation).
aData missing for four cases (2 cases mRS 0–2; 2 cases mRS 3).
*2/Fisher’s exact; yMann Whitney; zunpaired t test.
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Cases with missing data were omitted. We calculated
adjusted odds ratios (aORs) and hazard ratios (aHRs)
per 10mL increase in ICH, PHE and total lesion
volume. Model fit was assessed using the Akaike infor-
mation criterion (AIC), area under the receiver operat-
ing characteristic curve (AUC) measured by C-statistic,
and the Hosmer–Lemeshow test.
We attempted survival analysis of the entire fol-
low-up period available for each patient using Cox
proportional hazards modeling, with the same inde-
pendent variables as our logistic regression models.
However, 2 analysis of Schoenfeld residuals indicated
non-proportional hazards (Supplementary figure).
Using Kaplan–Meier analysis we determined that this
was due to high hazards of death 30 days post-ICH.
We therefore considered 30-day case fatality as a binary
outcome using logistic regression and used a Cox
regression model to analyze long-term survival in
the cohort of patients who survived beyond 30 days
after ICH.32 As just one patient with a baseline
GCS 3–4 survived to 30 days, we dichotomized GCS
(3–12 vs. 13–15) for these analyses. The distribution
of Schoenfeld residuals in this model indicated
that the assumption of proportionality was met.
We used the AUC and Wald test to compare
Cox models.
Regulatory approval
LATCH was approved by the NHS Caldicott
Guardian. Data were prospectively input to the audit
database according to an a priori prepared protocol.
For these analyses, we used anonymized data only, as
such, no ethics committee approval was required.
Similarly, no consent was required.
Results
Of 530 patients with incident ICH (Figure 1), 418 had
first-ever ICH without an identified underlying structural
cause, 359 were diagnosed by brain CT on day three or
earlier after symptom onset. After excluding two patients
with multifocal ICH and one with a CT scan unsuitable
for analysis, we included 356 patients. The median dur-
ation of follow-up from study opening until death or last
follow-up was 71 days (interquartile range (IQR)
3–1682) for the entire cohort, 2574 days (IQR 2141–
2944) for patients scored mRS 0–2 at one year and 12
days (IQR 2–544) for patients scored mRS 3–6 at one
year. Death and dependency at one year were assessed in
96% (342/356) of patients and survival data were 96%
complete (805/835 years of potential follow-up from
study opening to data extraction). Intra- and inter-
rater agreement about PHE volume was excellent (ICC
0.93 and 0.98, respectively).
Clinical characteristics and univariable analyses
The median age of this cohort was 78 years (IQR 68–
83) and 193 (54%) were female (Table 1). The median
time to CT scan from symptom onset or when last seen
well was 6.5 h (IQR 2.9–21.7). Older age, pre-existing
dementia, alcohol abstinence, antiplatelet use, and
paracetamol use at ICH onset were associated with
death or dependency at one year (Supplementary
Table 1). In these univariate analyses, higher baseline
ICH volume, PHE volume, EED, and intraventricular
hemorrhage (IVH) on diagnostic brain CT were asso-
ciated with one-year death or dependency (Table 1).
Admission GCS score was also associated with one-
year death or dependency (Table 1).
Figure 2. Scatterplots and regression analyses of ICH volume vs. PHE volume (a) or EED (b). Dots represent individual patients,
solid lines represent the modeled regression line, and dashed lines indicate 95% confidence intervals. R2 represents the proportion
of the variance for the dependent variable that is explained by the independent variable in the regression models.
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Collinearity of ICH and PHE metrics
PHE and ICH volumes (R2¼ 0.77)) were highly corre-
lated (Figure 2(a)). ICH volume and EED also highly
correlated according to a cubic function (R2¼ 0.87;
Figure 2(b)).
Functional outcome
We prespecified two multivariable models of
functional outcome at one year. Our first prespecified
model (Table 2) demonstrated no significant
independent association between PHE volume and
death or dependency but a significant association
between ICH volume and death or dependency
was identified after adjustment. Our second model
also demonstrated no significant association between
EED or ICH volume and death or dependency
(Table 2).
Both models exhibited instability, which sensitivity
analyses showed was attributable to collinearity
between ICH and PHE metrics. These sensitivity ana-
lyses with just one ICH or PHE metric per regression
model showed significant associations between one-
year death or dependency and greater ICH volume
(aOR 1.58 (1.26–2.09); p< 0.001), PHE volume (aOR
Table 2. Initial prespecified logistic regression models of death or dependency at one year after first-ever spontaneous ICH
Independent variables aOR
95% Confidence
interval p value
Area under
ROC curve
Akaike
information
criterion
Peri-hematomal edema volume
Intercept 0.017 0.00058–0.63 0.015 0.87 213.3
PHE volume (per 10 mL) 0.92 0.63–1.45 0.69
ICH volume (per 10 mL) 1.72 1.083–2.87 0.029
Age (per year) 1.072 1.04–1.11 <0.001
IVH 3.44 1.49–8.64 0.005
Infratentorial 1.89 0.64–6.56 0.27
GCS 3–4
GCS 5–12 1.29 0.047–14.39 0.85
GCS 13–15 0.45 0.019–4.062 0.54
Edema extension distance
Intercept 0.010 0.00025–0.48 0.013 0.87 213.0
EED (per cm) 1.38 0.92–2.24 0.17
ICH volume (per 10 mL) 1.38 0.56–3.39 0.48
Age (per year) 1.070 1.040–1.10 <0.001
IVH 3.49 1.51–8.75 0.005
Infratentorial 2.16 0.71–7.76 0.20
GCS 3–4
GCS 5–12 1.20 0.44–13.4 0.90
GCS 13–15 0.41 0.017–3.70 0.49
Adjusted odds ratio (OR) indicates adjusted risk of poor outcome (mRS 3–6) associated with increasing ICH or PHE volume (per 10 mL), OED (per
cm), age (per year), in the presence of IVH or infratentorial ICH, or GCS group (vs. GCS 3–4).
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1.47 (1.19–1.89); p¼ 0.001) and EED (aOR 2.52 (1.63–
4.06); p< 0.001; Supplementary Table 2).
Because PHE volume and EED were collinear with
ICH volume, we summed PHE and ICH volumes to
derive total lesion volume, a measure of total parenchy-
mal abnormality. Ten-milliliter increments in total
lesion volume, yearly increases in age, and the presence
of intraventricular hemorrhage were associated with
one-year death and dependency, independent of other
known predictors of outcome (Table 3).
We conducted an additional exploratory subgroup
analysis of functional outcome at one year in 30-day
survivors. In this subgroup, outcome was not independ-
ently associated with lesion volume (aOR 1.007
(0.998–1.30); p¼ 0.073; Supplementary Table 3).
Subgroup analyses stratified by ICH volume and
lobar versus deep/infratentorial ICH demonstrated
similar characteristics except that in small ICH
volumes, the associations of EED (aOR 9.036
(1.086–110.22); p¼ 0.059) and PHE volume (aOR
13.7 (1.20–268.51); p¼ 0.058) approached, but did not
achieve, statistical significance (Supplementary Tables 4
to 9). In a model using total lesion volume and the
same covariables as previously described, we undertook
a further exploratory sensitivity analysis using time
(in hours) from ICH symptom onset to diagnostic
CT scan as a supplementary covariable. This demon-
strated similar characteristics with a significant
association between longer time to CT and lower
odds of one-year death or dependency (aOR 0.87
(0.78–0.97; per 6-h increment); p¼ 0.011;
Supplementary Table 10).
Survival
One hundred sixty-two (46%) patients died within 30
days of ICH symptom onset and 293 (82%) died during
the entire follow-up period (Table 1; Figure 3). Total
lesion volume was independently associated with 30-
day case fatality (Table 4; Figure 3). In the cohort of
patients who survived >30 days from their ICH, lesion
volume was not independently associated with long-
term survival (Table 4; Figure 3).
Discussion
In this prospective, community-based cohort study of
patients scanned in a median time of 6 h after ICH
symptom onset, we did not find evidence of an associ-
ation between any measure of baseline PHE volume
with functional outcome that was independent of ICH
volume, because ICH volume and measures of PHE
were collinear. Total lesion (ICH and PHE) volume
was associated with poor functional outcome at one
year and 30-day case fatality after ICH. We found
that 30-day survivors had similar probabilities of
having a good outcome at one year and long-term sur-
vival irrespective of lesion volume on diagnostic CT
brain scan.
Comparison with other studies
Of four previous studies which have examined the asso-
ciation between PHE at baseline and poor outcome
after ICH using multivariable analyses to adjust for
Table 3. Final logistic regression model of death and dependency at one-year after first-ever spontaneous ICH
Independent variables aOR
95% Confidence
interval p value
Area under
ROC curve
Akaike
information
criterion
Intercept 0.0056 0.00015–0.74 <0.001 0.86 213.2
Total lesion volume (per 10 mL) 1.24 1.11–1.42 <0.001
Age (per year) 1.069 1.039–1.10 <0.001
IVH 3.63 1.58–9.04 0.004
Infratentorial 2.055 0.71–7.70 0.21
GCS 3–4
GCS 5–12 1.17 0.045–12.28 0.90
GCS 13–15 0.39 0.017–3.23 0.45
Adjusted OR indicates adjusted risk of poor outcome (mRS 3–6) associated with increasing total lesion volume (per 10 ml), age (per year), in the
presence of IVH or infratentorial ICH, or GCS group (versus GCS 3–4).
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ICH volume and other confounders, two found an
association (1337 and 10613 patients), one did not find
an association (596 patients)12 and one other (98
patients) found that greater relative PHE—the ratio
of PHE:ICH volume—was associated with better sur-
vival at 90 days.11 We assessed outcome at one year and
long-term survival whereas previous studies considered
outcome at 14,7 30,13 or 90 days.11,12 The previous
reports of an association between PHE and poor out-
come may be due to handling of ICH volume as a
dichotomous variable,7 or measurement of maximal
PHE area on a single axial image.13 Alternatively,
Figure 3. Kaplan–Meier curves of survival over up to nine years of follow-up in quartiles of lesion volume in the entire cohort (a)
or restricted to 30-day survivors (b). Shaded areas indicate 95% confidence intervals.
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selection bias may contribute to our differing findings;
since both studies which found an association had hos-
pital-based cohorts with smaller ICH volumes, for
which the effect of PHE may be more pro-
nounced.7,13,33 We did not observe a statistically signifi-
cant independent effect of PHE volume on outcome in
our analysis stratified by ICH volume, although the
effect of PHE approached significance in the subgroup
with smaller ICH volumes. The use of relative PHE
may produce disproportionately high PHE measure-
ments in smaller ICH volumes and consequent associ-
ation with good outcome.5,11
Strengths and limitations
We used a prospective community-based design with
multiple sources of case ascertainment and prospective
follow-up to identify adults with first ever spontaneous
ICH at or very shortly after ICH onset, thus
minimizing selection bias. Interventions which could
affect PHE were infrequently utilized in our cohort
and were spread similarly between outcome groups.
Further, our population was not drawn from a trial
and so there is low risk of interventions distorting out-
comes. Our sample size was sufficient to permit our pre-
specified multivariable analyses. Our images were refor-
matted into standardized axial, coronal, and sagittal
plains for analysis, which was undertaken in a standar-
dized fashion blind to clinical outcome. Imaging fea-
tures of ICH were classified by a neuroradiologist and
we were able to demonstrate high inter-observer agree-
ment for the assessment of PHE, indicating precision
with minimal measurement error. We prespecified the
covariables used for adjustment in our multivariable
analyses using known independent predictors of 30-
day outcome after ICH, described by the ICH score
which have been robustly established and validated.3,34
Other variables, such as systolic blood pressure,21,35
Table 4. Multivariable analysis of deaths after first-ever spontaneous ICH
Independent variables aOR/aHR
95% Confidence
interval p value
Area under
ROC curve
Akaike
information
criterion/Wald
30-day case fatality: logistic regression
Intercept 0.12 0.0069–3.75 0.16 0.89 309.6
Total lesion volume (per 10 mL) 1.22 1.15–1.30 <0.001
Age (per year) 1.025 1.0012–1.051 <0.042
IVH 2.82 1.57–5.10 <0.001
Infratentorial 3.44 1.48–8.10 0.004
GCS 3–4
GCS 5–12 0.09 0.0044–0.57 0.035
GCS 13–15 0.025 0.0012–0.15 0.001
Death in 30-day survivors: Cox proportional hazards
Total lesion volume (per 10 mL) 1.010 0.95–1.063 0.80 0.67 p¼ 2 109
Age (per year) 1.063 1.044–1.081 <0.001
IVH 1.40 0.96–2.055 0.088
Infratentorial 1.17 0.70–1.99 0.55
GCS 3–12
GCS 13–15 0.94 0.58–1.52 0.80
Analysis of deaths up to 30 days after ICH by logistic regression: aOR indicates adjusted risk of death by 30 days; Akaike information criterion analysis
of fit. Analysis of time to death in 30-day survivors by Cox proportional hazards; adjusted hazard ratio (HR) indicates adjusted hazards of death
associated with increasing total lesion volume (per 10 mL), age (per year), in the presence of IVH or infratentorial ICH, or GCS group (versus GCS 3–
4). Wald p value.
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and blood glucose at initial medical assessment, as well
as antithrombotic medication usage36,37 and diabetes
mellitus,38 have been associated with various outcomes
after ICH. However, these associations vary between
reports or have not been shown to predict outcome
independent of the ICH score components and were
therefore not included in our multivariable analysis.
By adjusting only for established predictors of out-
come, while avoiding exploratory analyses, the risk of
type two error or confounding obscuring our primary
finding is minimized.
We assessed PHE volume at baseline, on the first CT
scan done up to and including day three after ICH
symptom onset. We did not perform serial imaging,
which allows measurement of change in PHE volume
over time. Rate of change in PHE volume could be
associated with functional outcome independent of
ICH growth rate and our present study was unable
to determine this.4,30 We used CT as this is the most
commonly used imaging modality after ICH, is bet-
ter tolerated than MRI by elderly patients with acute
ICH and is reliable for the semi-automated assess-
ment of PHE.24 However, differentiating peri-hemato-
mal hypodensity due to PHE from white matter
lucencies related to small vessel disease is challenging
on CT images.24 Because some of our predictor vari-
ables are widely used clinically predict outcome after
ICH it is possible that they may have influenced clin-
icians decision making, thus becoming self-fulfilling
predictors.3
Conclusions
ICH volume and PHE measured on baseline CT scan
are colinear. As such, we found that there was no asso-
ciation between baseline PHE volume and death or
dependency at one year after ICH. Total lesion
volume incorporates both ICH and PHE volume and
was associated with death and dependency at 30 days
and one year after ICH. Patients who survived the first
month after ICH had similar risks of longer-term death
or disability, irrespective of their initial total lesion
volume. Future observational studies should consider
serial imaging to determine whether differences in the
evolution of ICH or PHE volumes over time are asso-
ciated with long-term outcome.
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